Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 85 results found. Search for [ drug pricing regulator ]

Results 1 to 21 of 85
PB Jayakumar
New Delhi, May 28, 2019
Domestic cancer drug sales are growing at 20 per cent annually for the past few years, while global growth is half of that


BusinessToday.In
May 27, 2019
The buzz is that Ranjan Pai-owned Manipal Hospitals has begun confirmatory due diligence on Medanta assets and an agreement is likely to be signed in the next 60 days


E Kumar Sharma
New Delhi, May 23, 2019
The pharma industry is today growing at around 11 per cent per annum as compared to a high of around 15 per cent about five years ago.


BusinessToday.In
New Delhi, May 17, 2019
In March, the rates were brought down for around 380 drugs, with some cuts going to as much as 80-90 per cent under trade margin rationalisation.


BusinessToday.In
New Delhi, May 14, 2019
The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases


BusinessToday.In
May 9, 2019
In as many as 666 cases, pharma companies are yet to disgorge excess profits accrued by overcharging customers under the Drug Prices Control Orders. The DoP has now made a one-time settlement offer on their total outstanding dues, provided they collectively cough up Rs 3,501 crore and drop their lawsuits


PTI
April 1, 2019



PTI
April 1, 2019



PTI
April 1, 2019



Joe C Mathew
New Delhi, March 19, 2019
In early March, the National Pharmaceutical Pricing Authority (NPPA), India's drug price regulator, fixed the ceiling prices of 463 brands of cancer medicines.


PTI
March 13, 2019



PTI
February 27, 2019



PTI
January 23, 2019



E Kumar Sharma
January 18, 2019
Globally, the number of diabetes patients is at around half a billion with over 30 million in the US alone, the most sought after market for diabetes care companies, especially those into insulin.


PTI
November 4, 2018



PTI
November 2, 2018



E. Kumar Sharma
New Delhi, October 29, 2018
Strides Pharma Science attributes its underwhelming performance to a confluence of headwinds and execution challenges.


PTI
October 24, 2018



PTI
June 13, 2018



E Kumar Sharma
New Delhi, May 25, 2018
Just prior to the results, on May 23, Sun Pharma had announced that the US drug regulator USFDA (US Food and Drug Administration) approved Yonsa, its drug to treat a kind of prostate cancer.


PAGES 1 OF 5  12345